Literature DB >> 21557700

Using a fuzzy controller optimized by a genetic algorithm to regulate blood glucose level in type 1 diabetes.

F Fereydouneyan1, A Zare, N Mehrshad.   

Abstract

In this paper a closed-loop control algorithm for blood glucose regulation in type 1 diabetic patients is proposed by using the Mamdani-type fuzzy method. Because of the presence of high-pass proportional derivatives in fuzzy designing, optimal values are applied for two inputs and one output membership functions in order to prevent the fluctuations due to derivatives in fuzzy design. Therefore, 19 values which are related to membership functions of the two inputs and one output are obtained by using a genetic algorithm (GA). The new model, termed the Augmented Minimal Model (AMM), is used in simulations. This controller is capable of stabilizing the blood glucose concentration at a normoglycaemic level of 90 mg dl(-1). The operation of the controller under various situations including multiple meal disturbances, and noise due to inaccurate effects of measuring blood glucose level are considered. Uncertainties in the meal disturbance function and variations of model parameters were also taken into consideration in simulations and the controller was found to be robust to such uncertainties.
Copyright © 2011 Informa UK, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557700     DOI: 10.3109/03091902.2011.569050

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  3 in total

1.  Artificial Intelligence Methodologies and Their Application to Diabetes.

Authors:  Mercedes Rigla; Gema García-Sáez; Belén Pons; Maria Elena Hernando
Journal:  J Diabetes Sci Technol       Date:  2017-05-25

2.  Performance Analysis of Fuzzy-PID Controller for Blood Glucose Regulation in Type-1 Diabetic Patients.

Authors:  Jyoti Yadav; Asha Rani; Vijander Singh
Journal:  J Med Syst       Date:  2016-10-06       Impact factor: 4.460

Review 3.  Artificial Intelligence for Diabetes Management and Decision Support: Literature Review.

Authors:  Ivan Contreras; Josep Vehi
Journal:  J Med Internet Res       Date:  2018-05-30       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.